BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24195508)

  • 1. Incidence of cytogenetic aberrations in two B lineage subpopulations in multiple myeloma patients analyzed by combination of whole-genome profiling and FISH.
    Smetana J; Dementyeva E; Kryukov F; Nemec P; Greslikova H; Kupska R; Mikulasova A; Ihnatova I; Hajek R; Kuglik P
    Neoplasma; 2014; 61(1):48-55. PubMed ID: 24195508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
    Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
    Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation of chromosomal aberrations with prognostic markers in multiple myeloma patients--a single institution study].
    Lee JW; Lee JK; Hong YJ; Hong SI; Chang YH
    Korean J Lab Med; 2008 Dec; 28(6):413-8. PubMed ID: 19127104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting plasma cells improves detection of cytogenetic aberrations in multiple myeloma: phenotype/genotype fluorescence in situ hybridization.
    Slovak ML; Bedell V; Pagel K; Chang KL; Smith D; Somlo G
    Cancer Genet Cytogenet; 2005 Apr; 158(2):99-109. PubMed ID: 15796956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
    Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
    Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic and molecular aberrations of multiple myeloma patients: a single-center study in Singapore.
    Lim AS; Lim TH; See KH; Ng YJ; Tan YM; Choo NS; Lim SX; Yee Y; Lau LC; Tien SL; Sathish K; Tan DC
    Chin Med J (Engl); 2013; 126(10):1872-7. PubMed ID: 23673102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of the Cytogenetic Aberrations in Multiple Myeloma by Using Microrray Comparative Genomic Hybridization].
    Wang YF; Wang H; Xi LY; Zhang ZH; Wang J; Dong F; Ke XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1389-1395. PubMed ID: 30295256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can genome array screening replace FISH as a front-line test in multiple myeloma?
    Boneva T; Brazma D; Gancheva K; Howard-Reeves J; Raynov J; Grace C; Nacheva EP
    Genes Chromosomes Cancer; 2014 Aug; 53(8):676-92. PubMed ID: 24757046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence in situ hybridization analysis of immunoglobulin heavy chain translocations in plasma cell myeloma using intact paraffin sections and simultaneous CD138 immunofluorescence.
    Cook JR; Hartke M; Pettay J; Tubbs RR
    J Mol Diagn; 2006 Sep; 8(4):459-65. PubMed ID: 16931586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal aberrations are shared by malignant plasma cells and a small fraction of circulating CD19+ cells in patients with myeloma and monoclonal gammopathy of undetermined significance.
    Zojer N; Schuster-Kolbe J; Assmann I; Ackermann J; Strasser K; Hübl W; Drach J; Ludwig H
    Br J Haematol; 2002 Jun; 117(4):852-9. PubMed ID: 12060120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization are complementary techniques to detect cytogenetic abnormalities in multiple myeloma.
    Alpar D; de Jong D; Holczer-Nagy Z; Kajtar B; Savola S; Jakso P; David M; Kosztolanyi S; Kereskai L; Pajor L; Szuhai K
    Genes Chromosomes Cancer; 2013 Sep; 52(9):785-93. PubMed ID: 23720363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic profiling of plasma cell disorders in a clinical setting: integration of microarray and FISH, after CD138 selection of bone marrow.
    Berry NK; Bain NL; Enjeti AK; Rowlings P
    J Clin Pathol; 2014 Jan; 67(1):66-9. PubMed ID: 23969274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evaluation of minimal residual disease in multiple myeloma by fluorescent molecular beacons in real time PCR of IgH gene rearrangements and correlation with flow cytometry.
    Kara IO; Duman BB; Afsar CU
    J BUON; 2013; 18(2):442-7. PubMed ID: 23818359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High incidence and intraclonal heterogeneity of chromosome 11 aberrations in patients with newly diagnosed multiple myeloma detected by multiprobe interphase FISH.
    Cremer FW; Kartal M; Hose D; Bila J; Buck I; Bellos F; Raab MS; Brough M; Moebus A; Hager HD; Goldschmidt H; Moos M; Bartram CR; Jauch A
    Cancer Genet Cytogenet; 2005 Sep; 161(2):116-24. PubMed ID: 16102581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomal changes detected by fluorescence in situ hybridization in patients with acute lymphoblastic leukemia.
    Zhang L; Parkhurst JB; Kern WF; Scott KV; Niccum D; Mulvihill JJ; Li S
    Chin Med J (Engl); 2003 Sep; 116(9):1298-303. PubMed ID: 14527352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma: an integrated genomics approach reveals a wide gene dosage effect.
    Agnelli L; Mosca L; Fabris S; Lionetti M; Andronache A; Kwee I; Todoerti K; Verdelli D; Battaglia C; Bertoni F; Deliliers GL; Neri A
    Genes Chromosomes Cancer; 2009 Jul; 48(7):603-14. PubMed ID: 19396863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple myeloma primary cells show a highly rearranged unbalanced genome with amplifications and homozygous deletions irrespective of the presence of immunoglobulin-related chromosome translocations.
    Largo C; Saéz B; Alvarez S; Suela J; Ferreira B; Blesa D; Prosper F; Calasanz MJ; Cigudosa JC
    Haematologica; 2007 Jun; 92(6):795-802. PubMed ID: 17550852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on molecular cytogenetic abnormalities in multiple myeloma].
    Liu SY; Li JY; Chen LJ; Huang JW; Pan JL; Qiu HR; Shen YF; Xu W; Xue YQ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Apr; 28(4):223-6. PubMed ID: 17877196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal heterogeneity in childhood myelodysplastic syndromes--challenge for the detection of chromosomal imbalances by array-CGH.
    Praulich I; Tauscher M; Göhring G; Glaser S; Hofmann W; Feurstein S; Flotho C; Lichter P; Niemeyer CM; Schlegelberger B; Steinemann D
    Genes Chromosomes Cancer; 2010 Oct; 49(10):885-900. PubMed ID: 20589934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic profiling of myeloma: the best approach, a comparison of cytogenetics, FISH and array-CGH of 112 myeloma cases.
    Rack K; Vidrequin S; Dargent JL
    J Clin Pathol; 2016 Jan; 69(1):82-6. PubMed ID: 26338801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.